25 phenotypes from multigenic genotypes

Allelic Composition Genetic Background	Annotated Term	Reference
Apoetm1Unc/Apoetm1Unc Lcattm1Hgc/Lcattm1Hgc involves: 129P2/OlaHsd * C57BL/6 * DBA	abnormal cholesterol homeostasis	J:75567
	abnormal circulating protein level	J:75567
	abnormal lipid homeostasis	J:75567
	normal homeostasis/metabolism phenotype	J:75567
Lcattm1Hgc/Lcattm1Hgc Ldlrtm1Her/Ldlrtm1Her involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * DBA	abnormal cholesterol homeostasis	J:75567, J:89015
	abnormal circulating protein level	J:75567
	abnormal lipid homeostasis	J:75567, J:89015
	decreased circulating glucose level	J:89015
	decreased circulating HDL cholesterol level	J:75567, J:89015
	decreased circulating insulin level	J:89015
	decreased circulating LDL cholesterol level	J:89015
	decreased lipoprotein lipase activity	J:89015
	normal homeostasis/metabolism phenotype	J:75567
	increased circulating cholesterol level	J:75567
	increased circulating triglyceride level	J:75567, J:89015
	increased circulating VLDL cholesterol level	J:75567, J:89015
Lcattm1Hgc/Lcattm1Hgc Tg(SREBP1a)7343Reh/? involves: 129 * C57BL/6 * C57BL/6J * SJL	abnormal glomerular capillary morphology	J:93775
	abnormal lipid homeostasis	J:93775
	abnormal podocyte morphology	J:93775
	abnormal proximal convoluted tubule morphology	J:93775
	abnormal renal glomerulus morphology	J:93775
	abnormal renal tubule morphology	J:93775
	albuminuria	J:93775
	decreased circulating HDL cholesterol level	J:93775
	decreased circulating LDL cholesterol level	J:93775
	decreased circulating triglyceride level	J:93775
	enlarged liver	J:93775
	expanded mesangial matrix	J:93775
	glomerulosclerosis	J:93775
	increased circulating cholesterol level	J:93775
	increased circulating phospholipid level	J:93775
	increased circulating VLDL cholesterol level	J:93775
	increased mesangial cell number	J:93775
	podocyte foot process effacement	J:93775